Global research effort leads to new findings on genes and obesity

October 11, 2010

October 10, 2010─(BRONX, NY) ─Two major international studies looking at data from a quarter of a million people around the globe have found a new set of genes associated with body fat distribution and obesity. Researchers at 280 institutions worldwide, including Albert Einstein College of Medicine of Yeshiva University, conducted the studies. The research, published in the October 10 online edition of Nature Genetics, sheds light on the biological processes involved in body fat distribution, possibly leading to new ways of treating obesity.

"These studies open the door to better understanding the mechanisms that lead to the most harmful forms of obesity, which can result in heart attack, stroke and diabetes," said Robert Kaplan, Ph.D., professor of epidemiology & population health at Einstein and a co-author of the studies. "The findings provide important leads for researchers who are working to develop new medications to treat or prevent obesity."

In one study, researchers identified 13 new gene regions where variations in DNA sequence can be linked to a person's fat distribution--whether they store fat around the mid-section or below the waist. In the second study, researchers found 18 new genetic variations associated with increased susceptibility to obesity. The first study included data from almost 200,000 people, while the second study included data from nearly 250,000 people. Both studies were led by researchers at Oxford University and the Medical Research Council (MRC) Epidemiology Unit in Cambridge, England.

Using data from the large sample pool helped reveal genes that are exerting very subtle effects on body weight. "A lot of the genes we found were surprises," said Dr. Kaplan. "For every one of the new genes identified, we now can pose several new research questions to find out why it is associated with obesity."

The first study looked at a person's waist-to-hip ratio, which indicates a person's body shape. Someone who stores more fat around the waist (apple-shaped) is at greater risk of developing type 2 diabetes and heart disease, compared with someone who stores fat mainly in the thighs and buttocks (pear-shaped). The researchers note that while there are clear differences in body shape between men, who are more likely to be apple-shaped, and women, who are likelier to be pear-shaped, the mechanisms underlying these differences are not well understood. They found that genetic variations linked to where a person's body fat collects have a markedly stronger impact on women than on men. They also found that the genetic influences on body fat distribution are generally not the same as those involved in the risk of obesity.

The genes identified in the first study explain only about one percent of the variation in waist-to-hip ratios among different people. "But just because the percentage is very small, it doesn't mean that the finding isn't biologically important," Dr. Kaplan said. "We've learned in other areas of medicine that seemingly small influences can have a large impact, such as the correlation of high cholesterol to heart disease, for example. While high cholesterol doesn't account for a huge fraction of heart attack risk, we have been able to reduce the risk of heart attack in many patients by lowering cholesterol."

In the second study, the researchers examined the association between genes and body mass index (BMI), a measure of whether an individual's weight is healthy for a person of his or her height. An adult with a BMI of 25-29.9 is considered overweight, while a person with a BMI of 30 or greater is defined as obese. The study found 18 new genetic regions linked to BMI, bringing the known DNA variations linked to BMI to 32.

The study also revealed that a person of average height who inherited many of the "BMI-increasing" gene variants would weigh 15 to 20 pounds more than another person who inherited few of these variants. However, despite this large difference, the 32 confirmed genetic variations explain only 1.45% of the variation in people's BMIs. This suggests that a person's weight can be influenced by many other factors yet to be discovered, the researchers say.

"Clearly, genetics is not the whole story when it comes to obesity," Dr. Kaplan said. "The prevalence of obesity has skyrocketed in recent years, especially here in the Bronx, and our genes have not changed in that short period of time. Environmental factors, ranging from what we eat to how physically active we are, play a large role. But genetics are important because they may help us in terms of finding new obesity treatments, which so far have proven disappointing."
-end-
The studies were carried out by the GIANT (Genetic Investigation of Anthropometric Traits) consortium, an international collaboration of more than 400 scientists who receive funding support from many funding agencies worldwide.

The papers, "Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index" and "Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution," were published in the October 10 online edition of Nature Genetics.

About Albert Einstein College of Medicine of Yeshiva University

Albert Einstein College of Medicine of Yeshiva University is one of the nation's premier centers for research, medical education and clinical investigation. During the 2009-2010 academic year, Einstein is home to 722 M.D. students, 243 Ph.D. students, 128 students in the combined M.D./Ph.D. program, and approximately 350 postdoctoral research fellows. The College of Medicine has 2,775 fulltime faculty members located on the main campus and at its clinical affiliates. In 2009, Einstein received more than $155 million in support from the NIH. This includes the funding of major research centers at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Through its extensive affiliation network involving five medical centers in the Bronx, Manhattan and Long Island - which includes Montefiore Medical Center, The University Hospital and Academic Medical Center for Einstein - the College of Medicine runs one of the largest post-graduate medical training programs in the United States, offering approximately 150 residency programs to more than 2,500 physicians in training. For more information, please visit www.einstein.yu.edu

Albert Einstein College of Medicine

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.